Therapeutic targeting of the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis in cancer

PW Stacpoole - JNCI: Journal of the National Cancer Institute, 2017 - academic.oup.com
The mitochondrial pyruvate dehydrogenase complex (PDC) irreversibly decarboxylates
pyruvate to acetyl coenzyme A, thereby linking glycolysis to the tricarboxylic acid cycle and …

Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment

A Hanna, LA Shevde - Molecular cancer, 2016 - Springer
Cancer poses a serious health problem in society and is increasingly surpassing
cardiovascular disease as the leading cause of mortality in the United States. Current …

The hedgehog signaling pathway: a viable target in breast cancer?

P Bhateja, M Cherian, S Majumder, B Ramaswamy - Cancers, 2019 - mdpi.com
The hedgehog (Hh) pathway plays a key role in embryonic development and stem cell
programs. Deregulation of the Hh pathway is a key driver of basal cell carcinoma, and …

The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostat

PW Stacpoole, CE McCall - Mitochondrion, 2023 - Elsevier
Found in all organisms, pyruvate dehydrogenase complexes (PDC) are the keystones of
prokaryotic and eukaryotic energy metabolism. In eukaryotic organisms these multi …

Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation

S Coni, SM Serrao, ZN Yurtsever, L Di Magno… - Cell death & …, 2020 - nature.com
ABSTRACT Eukaryotic Translation Initiation Factor 5A (EIF5A) is a translation factor
regulated by hypusination, a unique posttranslational modification catalyzed by …

The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma

L Lospinoso Severini, F Ghirga, F Bufalieri… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Medulloblastoma (MB) is a heterogeneous tumor of the cerebellum that is
divided into four main subgroups with distinct molecular and clinical features. Sonic …

Non-invasive metabolic imaging of brain tumours in the era of precision medicine

MM Kim, A Parolia, MP Dunphy… - Nature reviews Clinical …, 2016 - nature.com
The revolution in cancer genomics has uncovered a variety of clinically relevant mutations in
primary brain tumours, creating an urgent need to develop non-invasive imaging biomarkers …

SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma

L Lospinoso Severini, E Loricchio, S Navacci… - Cell Death & …, 2024 - nature.com
Abstract The Sonic Hedgehog (SHH) pathway is crucial regulator of embryonic development
and stemness. Its alteration leads to medulloblastoma (MB), the most common malignant …

Targeting GLI factors to inhibit the Hedgehog pathway

P Infante, R Alfonsi, B Botta, M Mori… - Trends in …, 2015 - cell.com
Hedgehog (Hh) signaling has emerged in recent years as an attractive target for anticancer
therapy because its aberrant activation is implicated in several cancers. Major progress has …

Phenformin inhibits hedgehog-dependent tumor growth through a complex I-independent redox/corepressor module

L Di Magno, S Manni, F Di Pastena, S Coni, A Macone… - Cell reports, 2020 - cell.com
The antidiabetic drug phenformin displays potent anticancer activity in different tumors, but
its mechanism of action remains elusive. Using Shh medulloblastoma as model, we show …